Acute effects of antiarrhythmic drugs on stable ventricular premature beats - Controlled comparison of lorcainide and lidocaine

G. Schmidt, G. Klein, A. Wirtzfeld

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Nineteen patients with refractory but stable ventricular premature beats (VPB) received 3 medications intravenously at 24-h intervals. Lorcainide (2 mg/kg) and placebo were given double-blind in randomized sequence and the third treatment was 100 mg lidocaine, the standard reference drug. Continuous ECG recordings were made for the first 2 hours after administration to study the antiarrhythmic effect; the stability of the arrhythmia, the absence of residual and of period effects, and the interdrug differences in efficacy were statistically evaluated. Lorcainide significantly reduced the frequency of VPB during the 2-hour period, whereas the effect of lidocaine was more short-lived. The median individual peak reduction in VPB was 96% for lorcainide and 47% for lidocaine. No significant reduction in VPB was observed with placebo. Adverse effects were acceptable with either active treatment.

Original languageEnglish
Pages (from-to)633-636
Number of pages4
JournalEuropean Journal of Clinical Pharmacology
Volume27
Issue number6
DOIs
StatePublished - Nov 1985

Keywords

  • acute antiarrhythmic effect
  • antiarrhythmic drugs
  • lidocaine
  • lorcainide
  • placebo
  • ventricular premature beats

Fingerprint

Dive into the research topics of 'Acute effects of antiarrhythmic drugs on stable ventricular premature beats - Controlled comparison of lorcainide and lidocaine'. Together they form a unique fingerprint.

Cite this